BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34789257)

  • 1. Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer.
    Xi G; Qiu L; Xu S; Guo W; Fu F; Kang D; Zheng L; He J; Zhang Q; Li L; Wang C; Chen J
    BMC Med; 2021 Nov; 19(1):273. PubMed ID: 34789257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram model combining macro and micro tumor-associated collagen signatures obtained from multiphoton images to predict the histologic grade in breast cancer.
    Xi G; He J; Kang D; Xu S; Guo W; Fu F; Liu Y; Zheng L; Qiu L; Li L; Wang C; Chen J
    Biomed Opt Express; 2021 Oct; 12(10):6558-6570. PubMed ID: 34745756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients.
    Xi G; Guo W; Kang D; Ma J; Fu F; Qiu L; Zheng L; He J; Fang N; Chen J; Li J; Zhuo S; Liao X; Tu H; Li L; Zhang Q; Wang C; Boppart SA; Chen J
    Theranostics; 2021; 11(7):3229-3243. PubMed ID: 33537084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen signature as a novel biomarker to predict axillary lymph node metastasis in breast cancer using multiphoton microscopy.
    Fang Y; Kang D; Guo W; Zhang Q; Xu S; Huang X; Xi G; He J; Wu S; Li L; Han X; Chen J; Zheng L; Wang C; Chen J
    J Biophotonics; 2022 Jun; 15(6):e202100365. PubMed ID: 35084104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aligned collagen is a prognostic signature for survival in human breast carcinoma.
    Conklin MW; Eickhoff JC; Riching KM; Pehlke CA; Eliceiri KW; Provenzano PP; Friedl A; Keely PJ
    Am J Pathol; 2011 Mar; 178(3):1221-32. PubMed ID: 21356373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
    Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
    Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of tumour-infiltrating lymphocytes based on the evaluation of frequency in patients with oestrogen receptor-positive breast cancer.
    He J; Fu F; Wang W; Xi G; Guo W; Zheng L; Ren W; Qiu L; Huang X; Wang C; Li L; Kang D; Chen J
    Eur J Cancer; 2021 Sep; 154():217-226. PubMed ID: 34293665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor collagen framework from bright-field histology images predicts overall survival of breast carcinoma patients.
    Morkunas M; Zilenaite D; Laurinaviciene A; Treigys P; Laurinavicius A
    Sci Rep; 2021 Jul; 11(1):15474. PubMed ID: 34326378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
    Zheng Y; Wu C; Yan H; Chen S
    Clin Chim Acta; 2020 Jul; 506():110-121. PubMed ID: 32156604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the Collagen Signature in the Tumor Microenvironment With Recurrence and Survival of Patients With T4N0M0 Colon Cancer.
    Chen W; Dong S; Liu X; Wang G; Xu S; Lei S; Zhuo S; Yan J
    Dis Colon Rectum; 2021 May; 64(5):563-575. PubMed ID: 33538520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
    Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
    EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
    Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
    J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
    Wu J; Li X; Teng X; Rubin DL; Napel S; Daniel BL; Li R
    Breast Cancer Res; 2018 Sep; 20(1):101. PubMed ID: 30176944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
    Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
    Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer.
    Chen J; Li Z; Han Z; Kang D; Ma J; Yi Y; Fu F; Guo W; Zheng L; Xi G; He J; Qiu L; Li L; Zhang Q; Wang C; Chen J
    BMC Cancer; 2023 Jun; 23(1):530. PubMed ID: 37296414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of immune infiltration with clinical outcomes in breast cancer patients: The 25-gene prognostic signatures model.
    Liu Y; Fu W; Chen W; Lin Y; Zhang J; Song C
    Cancer Med; 2021 Mar; 10(6):2112-2124. PubMed ID: 33626234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
    Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
    Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
    Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
    Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.